Company: HRTX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-060882
Chunk: 30

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 30
---
 stock. The Schedule 13G indicates that BlackRock, Inc. has sole voting power with respect to 8,370,033 shares of common stock and sole dispositive power with respect to 8,534,567 shares of common stock.

Based on information set forth in a Schedule 13G/A filed with the SEC on February 13, 2024 by Vanguard Group Inc. reporting beneficial ownership of 8,338,912 shares of common stock. The Schedule 13G/A indicates that Vanguard Group has shared voting power with respect to 160,021 shares of common stock, sole dispositive power with respect to 8,118,026 shares of common stock and shared dispositive power with respect to 220,886 shares of common stock.

Consists of 372,224 shares of common stock, 236,042 shares of common stock underlying stock options exercisable within 60 days of April 21, 2025 and 37,156 shares of common stock underlying restricted stock units vesting within 60 days of April 21, 2025.

Consists of 68,449 shares of common stock, 7,546 shares of common stock underlying stock options exercisable within 60 days of April 21, 2025 and 390 shares of common stock underlying restricted stock units vesting within 60 days of April 21, 2025.

Consists of 124,455 shares of common stock, 64,422 shares of common stock underlying stock options exercisable within 60 days of April 21, 2025 and 24,194 shares of common stock underlying restricted stock units vesting within 60 days of April 21, 2025.

Consists of 110,872 shares of common stock, 51,922 shares of common stock underlying stock options exercisable within 60 days of April 21, 2025 and 24,194 shares of common stock underlying restricted stock units vesting within 60 days of April 21, 2025.

Consists of 65,820 shares of common stock and 5,984 shares of common stock underlying stock options exercisable within 60 days of April 21, 2025.

Consists of 2,367 shares of common stock, 15,454 shares of common stock underlying stock options exercisable within 60 days of April 21, 2025 and 2,368 shares of common stock underlying restricted stock units vesting within 60 days of April 21,